These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 451484)
41. [Results of using a polyvalent vaccine against Pseudomonas aeruginosa in patients with burns treated at various therapeutic centers in Poland]. Bukowska D; Serafińska D; Zietkiewicz W; Rudowski W; Hoffman S; Uszyński H; Molski M; Hess C; Jonecko A; Popiel D Pol Tyg Lek; 1986 Dec; 41(49):1549-52. PubMed ID: 3108869 [No Abstract] [Full Text] [Related]
42. Protective properties and haemagglutinins in serum from humans and in serum from mice injected with a new polyvalent Pseudomonas vaccine. Jones RJ; Roe EA Br J Exp Pathol; 1975 Feb; 56(1):34-43. PubMed ID: 812544 [TBL] [Abstract][Full Text] [Related]
43. Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection. Gilleland HE; Gilleland LB; Staczek J; Harty RN; García-Sastre A; Palese P; Brennan FR; Hamilton WD; Bendahmane M; Beachy RN FEMS Immunol Med Microbiol; 2000 Apr; 27(4):291-7. PubMed ID: 10727884 [TBL] [Abstract][Full Text] [Related]
45. Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model. Barnea Y; Carmeli Y; Gur E; Kuzmenko B; Gat A; Neville LF; Eren R; Dagan S; Navon-Venezia S Plast Reconstr Surg; 2006 Jun; 117(7):2284-91. PubMed ID: 16772930 [TBL] [Abstract][Full Text] [Related]
46. Thermal injury-induced non-specific resistance to fatal Pseudomonas aeruginosa burn-infection in mice. Pinto M; Zehavi-Willner T Jpn J Exp Med; 1989 Oct; 59(5):189-96. PubMed ID: 2559218 [TBL] [Abstract][Full Text] [Related]
47. [Pyocyanic infection in burned patients. Immunitary protection]. Moyen EN; Lesage D; Romano P Nouv Presse Med; 1972 Apr; 1(14):947-50. PubMed ID: 4623061 [No Abstract] [Full Text] [Related]
48. Prevention of pseudomonas respiratory infection in a surgical intensive care unit. Polk HC; Borden S; Aldrete JA Ann Surg; 1973 May; 177(5):607-15. PubMed ID: 4634109 [No Abstract] [Full Text] [Related]
49. Efficiency of Pseudomonas aeruginosa vaccines in the prevention and treatment of Pseudomonas infections in burned patients. Ionescu A; Meitert E; Vasiliu S; Meitert T; Sima F; Savulian C; Milicescu S Arch Roum Pathol Exp Microbiol; 1981; 40(4):323-32. PubMed ID: 6803737 [No Abstract] [Full Text] [Related]
50. [Analysis of 240 cases of burn patients with Pseudomonas aeruginosa septicemia]. Yang XD Zhonghua Wai Ke Za Zhi; 1989 May; 27(5):292-3, 317. PubMed ID: 2806007 [TBL] [Abstract][Full Text] [Related]
51. [Results of a study of the safety, reactogenicity and immunologic effectiveness of pyoimmunogen in the immunization of volunteer donors]. Krokhina MA; Grishina IA; Arkhipova NA; Zarubina EK; Edvabnaia LS Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):95-8. PubMed ID: 7331614 [TBL] [Abstract][Full Text] [Related]
52. Prevalence and resistance of Pseudomonas aeruginosa in severely burned patients: a 10-year retrospective study. Lipový B; Rihová H; Hanslianová M; Gregorová N; Suchánek I; Brychta P Acta Chir Plast; 2010; 52(2-4):39-43. PubMed ID: 21749009 [TBL] [Abstract][Full Text] [Related]
53. Early protection by vaccines against Pseudomonas aeruginosa colonizing burns. Jones RJ; Lowbury EJ Br J Exp Pathol; 1972 Dec; 53(6):659-64. PubMed ID: 4630411 [TBL] [Abstract][Full Text] [Related]
54. Pseudomonas aeruginosa infection and vaccination in the rat. Kostiala AA J Med Microbiol; 1980 May; 13(2):201-12. PubMed ID: 6770090 [TBL] [Abstract][Full Text] [Related]